Literature DB >> 18429772

Infantile hemangiomas: how common are they? A systematic review of the medical literature.

Christine Kilcline1, Ilona J Frieden.   

Abstract

No published prospective studies have been published for several decades examining the incidence of hemangiomas. Older studies were performed before the delineation of "hemangiomas" from other vascular birthmarks was well-established. The objective of our study is to critically re-examine the literature reporting the incidence of infantile hemangiomas to determine if the true incidence is actually known. We performed both an electronic database search and hand search of the medical literature on the natural history of hemangiomas in full-term newborns and infants. A total of seven articles were found comprising two study populations: newborns <2 weeks of age and infants over the age of 2 weeks. All studies included samples sizes >500 patients including both hospital-based and primary care settings. Study designs ranged from retrospective chart reviews to cross-sectional cohort studies. Descriptive nomenclature was not uniform between studies, and all had methodologic limitations including problems of definition and study design. Studies estimating the true incidence of infantile hemangiomas are all many decades old and have significant methodologic issues limiting their ability to determine hemangioma incidence. Future studies in primary care settings using the currently accepted classification schema of vascular birthmarks may more accurately define the incidence and potential impact of this common vascular tumor of infancy.

Entities:  

Mesh:

Year:  2008        PMID: 18429772     DOI: 10.1111/j.1525-1470.2008.00626.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  79 in total

1.  Incidence and clinical characteristics of periocular infantile hemangiomas.

Authors:  Saba T Alniemi; Gregory J Griepentrog; Nancy Diehl; Brian G Mohney
Journal:  Arch Ophthalmol       Date:  2012-07

2.  Infantile hemangiomas: A review.

Authors:  Alison B Callahan; Michael K Yoon
Journal:  Saudi J Ophthalmol       Date:  2012-05-23

3.  A survey on clinical use of propranolol for infantile hemangiomas in mainland China.

Authors:  Zheng-Gang Chen; Jia-Wei Zheng; Ling Zhang; Ling Zhu; Yan-An Wang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  PHACE syndrome misdiagnosed as a port-wine stain.

Authors:  Jason Thomson; Aina Greig; Claire Lloyd; Danny Morrison; Carsten Flohr
Journal:  BMJ Case Rep       Date:  2015-07-15

Review 5.  A Basic Introduction to Pediatric Vascular Anomalies.

Authors:  Sarah N Eberson; Sudhen B Desai; Denise Metry
Journal:  Semin Intervent Radiol       Date:  2019-05-22       Impact factor: 1.513

6.  Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial.

Authors:  Kyu Han Kim; Tae Hyun Choi; Yunhee Choi; Young Woon Park; Ki Yong Hong; Dong Young Kim; Yun Seon Choe; Hyunjung Lee; Jung-Eun Cheon; Jung-Bin Park; Kyung Duk Park; Hyoung Jin Kang; Hee Young Shin; Jae Hoon Jeong
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

7.  Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study).

Authors:  Derek H Chu; Leslie Castelo-Soccio; Joy Wan; Joel M Gelfand; Robert E Shaddy; Kara N Shah; Marissa J Perman; James R Treat; Albert C Yan
Journal:  Clin Pediatr (Phila)       Date:  2014-05-21       Impact factor: 1.168

8.  Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma.

Authors:  Graham M Strub; Andrew L Kirsh; Mark E Whipple; Winston P Kuo; Rachel B Keller; Raj P Kapur; Mark W Majesky; Jonathan A Perkins
Journal:  JCI Insight       Date:  2016-09-08

9.  Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight.

Authors:  Katelyn R Anderson; Jennifer J Schoch; Christine M Lohse; Jennifer L Hand; Dawn M Davis; Megha M Tollefson
Journal:  J Am Acad Dermatol       Date:  2015-10-19       Impact factor: 11.527

10.  Developing a Nanoparticle-Delivered High-Efficacy Treatment for Infantile Hemangiomas Using a Mouse Hemangioendothelioma Model.

Authors:  Hakan Orbay; Yuanpei Li; Wenwu Xiao; Simon R Cherry; Kit Lam; David E Sahar
Journal:  Plast Reconstr Surg       Date:  2016-08       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.